Review
Pharmacological treatments for ADHD and the novel agent atomoxetine
Affiliations
- PMID: 13677007
Item in Clipboard
Review
Pharmacological treatments for ADHD and the novel agent atomoxetine
J Psychosoc Nurs Ment Health Serv.
2003 Aug.
No abstract available
Similar articles
-
Atomoxetine (strattera) for ADHD.Med Lett Drugs Ther. 2003 Feb 3;45(1149):11-2. Med Lett Drugs Ther. 2003. PMID: 12571539 No abstract available.
-
Atomoxetine for attention deficit/hyperactivity disorder.Issues Emerg Health Technol. 2003 May;(46):1-4. Issues Emerg Health Technol. 2003. PMID: 12751480
-
[Atomoxetine for the treatment of attention-deficit/hyperactivity disorder].Fortschr Neurol Psychiatr. 2004 Oct;72(10):586-91. doi: 10.1055/s-2004-830049. Fortschr Neurol Psychiatr. 2004. PMID: 15472782 German.
-
Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder.Arch Dis Child. 2005 Feb;90 Suppl 1(Suppl 1):i26-9. doi: 10.1136/adc.2004.059386. Arch Dis Child. 2005. PMID: 15665154 Free PMC article. Review.
-
Safety profile of atomoxetine in the treatment of children and adolescents with ADHD.J Clin Psychiatry. 2002;63 Suppl 12:50-5. J Clin Psychiatry. 2002. PMID: 12562062 Review.
Cited by
-
Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system.Front Pharmacol. 2023 Aug 14;14:1208456. doi: 10.3389/fphar.2023.1208456. eCollection 2023. Front Pharmacol. 2023. PMID: 37645441 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical